Key Points
- Director Jonathan Rothberg sold 176,070 shares on Dec. 9 at an average price of $3.11 for a total of $547,577.70, leaving him with 111,031 shares — a 61.33% reduction in his ownership.
- In the latest quarter Butterfly Network reported EPS of ($0.04) versus a ($0.06) consensus and revenue of $21.49 million, but remains unprofitable with a -90.31% net margin and negative return on equity.
- Analysts’ consensus is a Hold with a $3.00 price target; the stock trades near $3.05, has a market cap of about $769 million, and a 52‑week range of $1.32–$4.98.
Butterfly Network, Inc. (NYSE:BFLY - Get Free Report) Director Jonathan Rothberg sold 176,070 shares of the business's stock in a transaction dated Tuesday, December 9th. The stock was sold at an average price of $3.11, for a total transaction of $547,577.70. Following the completion of the transaction, the director directly owned 111,031 shares in the company, valued at $345,306.41. This trade represents a 61.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Butterfly Network Stock Performance
NYSE BFLY opened at $3.05 on Thursday. The company has a market capitalization of $769.17 million, a PE ratio of -9.23 and a beta of 2.34. Butterfly Network, Inc. has a 52-week low of $1.32 and a 52-week high of $4.98. The company has a 50-day simple moving average of $2.51 and a 200 day simple moving average of $2.09.
Butterfly Network (NYSE:BFLY - Get Free Report) last posted its quarterly earnings results on Friday, October 31st. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.02. Butterfly Network had a negative return on equity of 37.80% and a negative net margin of 90.31%.The company had revenue of $21.49 million during the quarter, compared to the consensus estimate of $21.23 million. As a group, analysts forecast that Butterfly Network, Inc. will post -0.35 EPS for the current fiscal year.
Analysts Set New Price Targets
BFLY has been the subject of several research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Butterfly Network in a research report on Wednesday, October 8th. Wall Street Zen upgraded Butterfly Network from a "sell" rating to a "hold" rating in a report on Sunday, November 23rd. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Butterfly Network currently has an average rating of "Hold" and a consensus price target of $3.00.
Read Our Latest Stock Report on Butterfly Network
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Ashton Thomas Private Wealth LLC purchased a new position in shares of Butterfly Network in the second quarter worth about $25,000. CTC Alternative Strategies Ltd. bought a new position in Butterfly Network during the 1st quarter worth approximately $29,000. Ameriprise Financial Inc. purchased a new position in Butterfly Network in the 3rd quarter worth approximately $25,000. Deutsche Bank AG purchased a new position in Butterfly Network in the 1st quarter worth approximately $31,000. Finally, BNP Paribas Financial Markets boosted its stake in shares of Butterfly Network by 707.2% during the second quarter. BNP Paribas Financial Markets now owns 16,258 shares of the company's stock valued at $33,000 after purchasing an additional 14,244 shares during the period. 37.85% of the stock is owned by institutional investors.
Butterfly Network Company Profile
(
Get Free Report)
Butterfly Network, Inc develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
